This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Apr 10;34(11):1167-9.

doi: 10.1200/JCO.2015.64.8683. Epub 2015 Dec 28.

ABVD or BEACOPP for Advanced Hodgkin Lymphoma

Andreas Engert¹

Affiliations

PMID: 26712223
DOI: 10.1200/JCO.2015.64.8683

Editorial

ABVD or BEACOPP for Advanced Hodgkin Lymphoma

Andreas Engert. J Clin Oncol. 2016.

. 2016 Apr 10;34(11):1167-9.

doi: 10.1200/JCO.2015.64.8683. Epub 2015 Dec 28.

Author

Andreas Engert¹

Affiliation

¹ University Hospital of Cologne, Cologne, Germany a.engert@uni-koeln.de.

PMID: 26712223
DOI: 10.1200/JCO.2015.64.8683

No abstract available

PubMed Disclaimer

Comment on

Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Merli F, Luminari S, Gobbi PG, Cascavilla N, Mammi C, Ilariucci F, Stelitano C, Musso M, Baldini L, Galimberti S, Angrilli F, Polimeno G, Scalzulli PR, Ferrari A, Marcheselli L, Federico M. Merli F, et al. J Clin Oncol. 2016 Apr 10;34(11):1175-81. doi: 10.1200/JCO.2015.62.4817. Epub 2015 Dec 28. J Clin Oncol. 2016. PMID: 26712220 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information